VonCasper Solutions
Pioneering the future of automated clinical study design compilation and eClinical local infrastructure.
Corporate Mission & Narrative
VonCasper Solutions was founded to solve a critical bottleneck in biotechnology research: the 12-to-17-week startup latency involved in manually compiling clinical database structures from trial protocols.
Manual translation errors, fragmented email threads, and multi-tenant SaaS security audits slow down drug launch timelines. In blockbuster drug programs, every single day of clinical trial setup delay costs sponsors up to $8M in peak-sale patent commercial lifespan.
By developing G-Flow, a secure, local-first Protocol Compiler, we enable clinical teams to parse raw protocol documents and compile production-ready CDASH v1.3 variables and Medidata Rave ALS files in under 24 hours—eliminating weeks of manual database programming and protecting valuable patent life.
The Three Core Value Props (Our Moat Pillars)
🛡️ Local-First Sovereignty
Runs natively on Dell Pro Max GB10 on-premises container micro-workstations. Keeps pre-publication study design and trial protocol IP inside your company firewall, bypassing 6-to-12-month cloud InfoSec vendor reviews.
🎯 Extractive Grounding
Every compiled database schema, variable mapping, and edit check is mathematically bound back to the source protocol PDF via exact coordinates (charInterval offsets). Eliminates AI hallucinations and simplifies QA audits.
🖋️ The Consensus Gate
Enforces strict digital signature sign-offs on the study canvas from the Data Manager, Study Designer, Biostatistician, and Sponsor Reviewer before the compiled ALS database file can be unlocked and exported.
Heritage & Corporate Metadata
VonCasper Solutions is built on 30 years of systems integration and software engineering experience across high-security MedTech and FinTech environments. We align automated eClinical workflows with the FDA’s modern AI and software lifecycle mandates.